为什么对寄生虫的免疫力需要很长时间才能形成？
Why does immunity to parasites take so long to develop?
出版信息
Nat Rev Immunol. 2010 Feb;10(2):80-1. doi: 10.1038/nri2673.
Abstract
‘Maria Yazdanbakhsh and David Sacks discuss the various immune evasion strategies employed by human parasite pathogens to secure their transmission and that underlie the chronicity of infection and disease.’
摘要
‘玛丽亚·亚兹丹巴什和大卫·萨克斯讨论了人类寄生虫病原体为确保传播而采用的各种免疫逃避策略，这些策略是感染和疾病慢性化的基础。’
相似文献
1
Why does immunity to parasites take so long to develop?
Nat Rev Immunol. 2010 Feb;10(2):80-1. doi: 10.1038/nri2673.
2
Transgenic parasites: improving our understanding of innate immunity to malaria.
Cell Host Microbe. 2007 Aug 16;2(2):75-6. doi: 10.1016/j.chom.2007.07.007.
3
Acquisition of human plasminogen facilitates complement evasion by the malaria parasite Plasmodium falciparum.
Eur J Immunol. 2021 Feb;51(2):490-493. doi: 10.1002/eji.202048718. Epub 2020 Nov 15.
4
Plasmodium falciparum erythrocyte invasion: combining function with immune evasion.
PLoS Pathog. 2014 Mar 20;10(3):e1003943. doi: 10.1371/journal.ppat.1003943. eCollection 2014 Mar.
5
Attenuated Parasite Shows Cytokine Variations in Humanized Mice.
Front Immunol. 2020 Sep 11;11:1801. doi: 10.3389/fimmu.2020.01801. eCollection 2020.
6
7
Immunoglobulin M: Restrainer of Inflammation and Mediator of Immune Evasion by Plasmodium falciparum Malaria.
Trends Parasitol. 2016 Feb;32(2):108-119. doi: 10.1016/j.pt.2015.09.007. Epub 2015 Nov 18.
8
Antigenic variation and immune evasion in Plasmodium falciparum malaria.
Immunol Cell Biol. 1996 Dec;74(6):546-54. doi: 10.1038/icb.1996.88.
9
Molecular basis for evasion of host immunity and pathogenesis in malaria.
Biochim Biophys Acta. 1998 Feb 27;1406(1):10-27. doi: 10.1016/s0925-4439(97)00078-1.
10
Age-structured gametocyte allocation links immunity to epidemiology in malaria parasites.
Malar J. 2007 Sep 12;6:123. doi: 10.1186/1475-2875-6-123.
引用本文的文献
1
The immunology of parasite infections: Grand challenges.
Front Parasitol. 2022 Nov 8;1:1069205. doi: 10.3389/fpara.2022.1069205. eCollection 2022.
2
A molecular signature for IL-10-producing Th1 cells in protozoan parasitic diseases.
JCI Insight. 2023 Dec 22;8(24):e169362. doi: 10.1172/jci.insight.169362.
3
The Molecular Mechanisms Employed by the Parasite (Cnidaria: Myxozoa) from Invasion through Sporulation for Successful Proliferation in Its Fish Host.
Int J Mol Sci. 2023 Aug 15;24(16):12824. doi: 10.3390/ijms241612824.
4
A Novel Vaccine Strategy to Prevent Cytauxzoonosis in Domestic Cats.
Vaccines (Basel). 2023 Mar 2;11(3):573. doi: 10.3390/vaccines11030573.
5
Infection by the Parasite (Cnidaria: Myxozoa) Suppresses the Immune System of Hybrid Tilapia.
Microorganisms. 2022 Sep 23;10(10):1893. doi: 10.3390/microorganisms10101893.
6
CD300a Receptor Blocking Enhances Early Clearance of From Its Mammalian Host Through Modulation of Effector Functions of Phagocytic and Antigen Experienced T Cells.
Front Immunol. 2022 Jan 18;12:793611. doi: 10.3389/fimmu.2021.793611. eCollection 2021.
7
Helminth-induced Th2 cell dysfunction is distinct from exhaustion and is maintained in the absence of antigen.
PLoS Negl Trop Dis. 2019 Dec 9;13(12):e0007908. doi: 10.1371/journal.pntd.0007908. eCollection 2019 Dec.
8
Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites.
Nat Commun. 2019 Sep 2;10(1):3950. doi: 10.1038/s41467-019-11819-0.
9
Sensitivity and specificity of recombinant proteins in Toxocara spp. for serodiagnosis in humans: Differences in adult and child populations.
PLoS One. 2018 Dec 13;13(12):e0208991. doi: 10.1371/journal.pone.0208991. eCollection 2018.
10
Changes in parasite traits, rather than intensity, affect the dynamics of infection under external perturbation.
PLoS Comput Biol. 2018 Jun 11;14(6):e1006167. doi: 10.1371/journal.pcbi.1006167. eCollection 2018 Jun.
本文引用的文献
1
Regulation of pathogenesis and immunity in helminth infections.
J Exp Med. 2009 Sep 28;206(10):2059-66. doi: 10.1084/jem.20091903. Epub 2009 Sep 21.
2
Animal defenses against infectious agents: is damage control more important than pathogen control.
PLoS Biol. 2008 Dec 23;6(12):e4. doi: 10.1371/journal.pbio.1000004.
3
Acquired immunity to malaria.
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents. doi: 10.1128/CMR.00025-08.
4
Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases.
Nat Rev Immunol. 2008 Nov;8(11):889-95. doi: 10.1038/nri2432.
5
Immunity to malaria: more questions than answers.
Nat Immunol. 2008 Jul;9(7):725-32. doi: 10.1038/ni.f.205.
6
Interleukin-10 and the pathogenesis of human visceral leishmaniasis.
Trends Immunol. 2007 Sep;28(9):378-84. doi: 10.1016/j.it.2007.07.004. Epub 2007 Aug 6.
7
The role of antibodies to Plasmodium falciparum-infected-erythrocyte surface antigens in naturally acquired immunity to malaria.
Trends Microbiol. 2002 Feb;10(2):55-8. doi: 10.1016/s0966-842x(01)02278-8.
8
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.
J Exp Med. 2001 Nov 19;194(10):1497-506. doi: 10.1084/jem.194.10.1497.
9
Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age.
Infect Immun. 1999 Jul;67(7):3444-51. doi: 10.1128/IAI.67.7.3444-3451.1999.
10
Immunity to non-cerebral severe malaria is acquired after one or two infections.
Nat Med. 1999 Mar;5(3):340-3. doi: 10.1038/6560.
Zotero 插件